The latest round of data on the 2011 Census shows that the country is exhibiting distinct signs of trading up as material living conditions improve for large sections of the population. Although this aggregate picture is not uniform across the country, analysts believe that the upward material mobility in society is creating the basis of a new consumer boom in the economy—serving up a perfect backdrop ahead of the presentation of...

-The Hindu As it stands on the threshold of the Twelfth Plan, India has a historic opportunity to elevate education and healthcare as the strongest pillars of its future development. Yearning for life-building education is unprecedented today. Yet, as Amartya Sen pointed out last year, the system remains deeply unjust. Access to excellence is open to those who can afford it, while the less-affluent majority has been left behind without even...

-The Hindu Business Line A Government report has called for enhancing investment in agriculture and leveraging technology to boost the country's farm sector growth in the years ahead. The report ‘State of Indian Agriculture 2011-12,' released by the Agriculture Ministry on Tuesday, called for institutional reforms in research set up to make it more accountable and geared towards delivery, conservation of natural resources such as water and land among others. “Achieving a 8-9...

-The Indian Express   Increasing farm production and removing market imperfections would help in controlling prices of commodities, a report has said. The report on 'State of Indian Agriculture 2011-12', tabled in the Lok Sabha, said that the principal factors behind the higher levels of inflation in the recent period are constraints in production and distribution especially in high value items such as pulses, fruits and vegetables, egg and meat. Increase in prices can...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...